Basket | Login


Information on the European “PharmaCog” project now available on Alzheimer Europe’s website

Saturday 30 October 2010

Details of the European project “Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development” (PharmaCog) are now available on the Alzheimer Europe website. Information is divided under the following headings:

  • Why PharmaCog?
  • The PharmaCog approach
  • How will PharmaCog benefit patients?
  • Who are the PharmaCog partners?
  • Who supports PharmaCog?
  • Key contacts
  • Publications and conferences and
  • News

The PharmaCog project started in January 2010 and combines the efforts of academic institutions, global pharmaceutical companies, small and medium enterprises and patient representation from Alzheimer Europe.


For further information on PharmaCog please see the Alzheimer Europe website at: